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Summary  Brucellosis  is  an  infectious  disease  caused  by  Gram-negative  coccobacilli.  Direct
contact with  the  infected  tissue  or  blood,  consumption  of  infected  dairy  products,  and  inhala-
tion of  infectious  aeresol  particles  can  transmit  the  disease.  Brucella  endocarditis  is  rare  but
the most  fatal  complication  of  brucellosis.  The  most  commonly  involved  valve  is  aortic  valve.
Mycotic aneurysms  result  as  an  involvement  of  central  nervous  system  and  can  lead  to  serious
complications.  Herein  we  present  a  case  with  mycotic  aneurysmal  rupture  and  aortic  insuff-
icency and  sinus  valsalva  ﬁstula  caused  by  brucella  endocarditis.  There  were  rare  cases  with
brucella endocarditis  and  mycotic  aneursymal  rupture  secondary  to  neurobrucellosis  in  the  liter-






i© 2011  Japanese  College  of
Introduction
Brucellosis  is  an  infectious  disease  and  caused  by  Gram-
negative  coccobacilli.  Direct  contact  with  the  infected
tissue  or  blood,  consumption  of  infected  dairy  products,  and
inhalation  of  infectious  aerosol  particles  can  transmit  the
disease.  There  are  cases  reported  which  were  transmitted
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ia  sexual  contact  and  breastfeeding  [1].  Although  fever,
ight  sweats,  weight  loss,  and  myalgia  are  common  symp-
oms,  various  symptoms  can  be  seen  according  to  the
nvolved  system  [1].  Neurobrucellosis  and  brucella  endo-
arditis  are  rare  but  fatal  complications  of  the  disease.
ortic  valve  involvement  is  common  in  endocarditis.  Menin-
itis  and  meningoencephalitis  are  much  more  commonly
een  in  neurobrucellosis,  but  mycotic  aneurysms  can  also
e  seen  [2,3].In our  case  there  were  aortic  insufﬁciency  and  rupture
f  sinus  valsalva  due  to  brucella  endocarditis  and  rup-
ure  of  mycotic  aneurysm  as  a  result  of  neurobrucellosis.
hose  complications  were  successfully  treated  with  medical
Published by Elsevier Ltd. All rights reserved.










































Table  1  Patient’s  cerebrospinal  ﬂuid,  blood  biochemical,
and hematological  parameters.
Value  Reference
values
Complete  blood  count
Hemoglobin  (g/dl)  10.8  12.0—16.0
Hematocrit  (%)  30.7  35.0—52.0
White blood  cell  (103/mm3)  4.66  4.8—10.8
Mean corpuscular  volume  (ﬂ) 76.9  80.0—102.0
Red cell  distribution  width  (%) 13.2  11.5—15.5
Thrombocyte  (103/mm3) 183.0  150.0—450.0
Blood biochemistry
Glucose  (mg/dl) 128.00  70.0—105.0
Blood urea  nitrogen  (mg/dl)  24.00  6.0—20.0
Creatinine  (mg/dl)  0.91  0.50—1.10
Alanine  aminotransferase  (U/L)  8.0  0.0—31.0
Aspartate  aminotransferase  (U/L)  13.0  0.0—32.00
Total bilirubin  (mg/dl)  0.31  0.10—1.10
Direct bilirubin  (mg/dl)  0.01  0.00—0.30
Na (mEq/L)  139.0  133.0—145.0
K (mEq/L)  4.88  3.30—5.10
Sedimentation  (mm/h)  44  0.0—20.0
C-reactive  protein  (mg/dl)  2.18  0.0—0.5
Cerebrospinal  ﬂuid  biochemistry
Glucose  (mg/dl) 39.0  40.0—70.0
Protein  (mg/dl) 115.0  0.0—45.0












herapy,  surgery,  and  endovascular  intervention.  There  were
are  complications  with  brucella  endocarditis  and  mycotic
neursymal  rupture  secondary  to  brucellosis.
ase report
 29-year-old  male  patient  was  admitted  to  our  hospital
ith  symptoms  of  fever,  night  sweats,  decreased  functional
apacity,  weight  loss  of  8  kg  over  5  months  and  headache,
iplopia,  and  ataxia  for  one  week.  He  had  a  history  of
onsumption  of  raw  dairy  products,  he  was  admitted  to
nother  hospital  4  months  before  with  those  symptoms  and
e  was  diagnosed  as  having  brucellosis  with  brucella  tube
gglutination  titers  of  1/320  and  positive  Rose  Bengal  test.
oxycycline  and  rifampicin  were  prescribed,  but  he  failed
o  continue  treatment.
On  physical  examination,  he  was  concious,  well  oriented
nd  cooperative,  blood  pressure  was  100/60  mmHg,  pulse
ate  was  88  beats  per  minute,  temperature  was  38 ◦C  and
here  was  audible  aortic  diastolic  murmur.  There  were  no
igns  of  Kernig  and  Brudzinski.  Other  physical  examination
ndings  were  all  normal.  Hypochromic  microcytic  anemia,
eukopenia,  high  erythrocyte  sedimentation  rate  (ESR)  and
-reactive  protein  levels  were  found  on  laboratory  exams
Table  1).  Brucella  tube  agglutination  test  titers  were  1/640
ositive  and  Brucella  IgG  (+).  Lumbar  puncture  was  per-
ormed  and  there  were  130  leucocytes/mm3 and  dominancy
f  lymphocytes.  On  biochemical  exams  of  cerebrospinal
uid  (CSF),  glucose  was  39  mg/dl,  protein  115  mg/dl,  Cl
19  mEq/L,  and  lactate  2874  mmol/L  (Table  1).  CSF  was
egative  for  Brucella  tube  agglutination  and  there  were
o  agents  seen  on  Gram  and  Erlich—Ziehl—Nielsen  stains.
lood,  urine,  and  CSF  cultures  were  collected  and  doxy-
yline,  rifampicin,  and  ceftriaxone  combination  treatment
as  started  with  the  prediagnosis  of  neurobrucellosis.  Com-
uterized  tomography  performed  for  the  patient  because  of
eurologic  symptoms  and  a  hyperdense  image  compatible
ith  suspected  arteriovenous  malformation  located  at  right
halamus  extending  to  hypocampal  area  was  detected.  For
ifferential  diagnosis,  a  cranial  magnetic  resonance  imaging
can  with  angiography  was  performed  and  aneurysm  of  right
osterior  cerebral  artery  and  a  subacute  phase  hemorhagic
one  at  right  thalamus  extending  to  parahypocampal  and





igure  1  (Left  panel)  Magnetic  resonance  image  of  the  subacute  ph
esonance angiographic  image  of  aneurysm  of  right  posterior  cerebrLactate  2874  1100—2400
elective  cerebral  angiography  was  performed  and  right  pos-
erior  cerebral  artery  mid  zone  aneurysm  was  seen.  Patient
as  referred  to  the  neurosurgery  clinic,  but  no  operation
as  planned  for  the  patient.  Aneurysm  development  was
ssumed  to  be  mycotic  and  because  of  a murmur  heard  on
ardiac  oscultation,  echocardiography  was  performed  for
he  patient  to  determine  whether  the  mycotic  aneurysm  was
econdary  to  infective  endocarditis.  Dilatation  of  left  ven-
ricular  cavity  with  a  preserved  ejection  fraction  of  58%,
icuspid  aortic  valve,  a  mobile  vegetation  formation  on
ight  aortic  cusp,  severe  aortic  insufﬁciency,  and  a  ﬁstula
etween  aorta  and  right  atrium  as  a  result  of  ruptured  right
inus  valsalva  were  detected  on  echocardiography  (Fig.  2).
ase  hemorhagic  zone  at  right  thalamus.  (Right  panel)  Magnetic
al  artery.
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abetween aorta  and  right  atrium  as  a  result  of  ruptured  right  sin
of vegetation  on  aortic  cusp.  LA,  left  atrium;  RA,  right  atrium;  
Ceftriaxone  treatment  was  stopped  and  co-trimaxazole  was
initiated  with  a  diagnosis  of  endocarditis.  CSF  cultures  were
sterile  but  Brucella  melitensis  was  isolated  in  blood  cul-
tures.  On  the  tenth  day  of  treatment  surgery  was  performed;
aortic  valve  replacement  (No:  21,  St.  Jude,  St.  Paul,  MN,
USA)  and  ﬁstulous  aortic  segment  was  repaired  with  Goretex
graft  (Gore,  Newark,  DE,  USA)  and  pericardium.  The  antibi-
otic  regimen  was  continued  after  the  operation  and  blood
cultures  after  one  month  of  operation  were  sterile.  Because
of  cerebral  aneurysm,  the  patient  was  discharged  with  enox-
oparine  instead  of  warfarin.  The  patient  was  followed  up
for  two  months  with  oral  antibiotics  and  enoxoparine.  A
control  angiography  was  performed  for  cerebral  aneurysm
and  percutaneous  embolization  was  perfomed  for  persisting
aneurysm  (Fig.  3).  After  the  procedure  warfarin  was  started.
The  patient  is  still  being  followed  up  in  a  healthy  condition
after  the  ﬁfth  month  since  diagnosis  and  treatment  with  oral
antibiotics  and  warfarin.
DiscussionBrucella  endocarditis  is  responsible  for  3—4%  of  all  endo-
carditis  cases.  In  brucellosis  prevelance  of  endocarditis




Figure  3  (Left  panel)  Angiographic  image  of  right  posterior  cer
embolized posterior  cerebral  artery  aneurysm.lsalva.  (Right  panel)  Transesophageal  echocardiographic  image
ight  ventricle.
omplication  of  brucella  infections  but  is  responsible  for  80%
f  mortality  [1,5,6].  Mortality  is  usually  caused  by  cardiac
ailure  especially  in  patients  with  late  diagnosis.  In  endo-
arditis  cases,  the  most  isolated  forms  are  B.  abortus  and  B.
elitensis.  B.  melitensis  causes  more  acute  and  serious  clin-
cal  presentations.  As  in  our  case,  the  aortic  valve  is  most
ommonly  involved.  Involvement  of  prosthetic  valves  and
athologic  valves  are  commonly  seen,  but  native  valves  are
lso  seen  [2,5,7,8].  Diagnosis  of  brucella  endocarditis  can
e  made  with  history,  clinical  ﬁndings,  echocardiographic
mages  conﬁrming  the  diagnosis  of  infective  endocarditis,
solation  of  the  agent  from  tissue  samples,  positive  agglluti-
ation  test,  and  polymerase  chain  reaction  tests  [9].  The
gent  cannot  be  isolated  in  blood,  because  it  is  hard  to
roduce  in  cultures  and  there  is  a  long  interval  with  antibi-
tic  treatment  between  the  symptom  onset  and  diagnosis.
ecause  of  these  reasons  agglutination  tests  can  be  used  in
arly  diagnosis  [2,3,5,9].  Titers  of  tube  agglutination  above
/160  can  help  diagnosis  [9].  Diagnosis  in  our  case  could
e  made  by  history  of  consumption  of  raw  dairy  products
nd  previous  brucellosis  diagnosis,  clinical  and  echocar-
iographic  presentation,  positive  agglutination  tests,  and
solation  of  B.  melitensis  in  blood  samples.
Because  of  resistance  of  brucella  to  medical  treat-
ent,  and  persistence  in  tissue  for  up  to  eight  weeks  after


































































reatment  initiation  despite  effective  antibiotic  treatment,
edical  and  surgical  treatment  combination  approach  is  rec-
mmended.  In  selected  cases  without  cardiac  failure  and
ith  a  short  disease  interval  medical  treatment  can  be  suf-
cient  alone  but  recurrence  risk  is  high  [10]. Vegetation,
mbolization,  development  of  cardiac  failure,  valvular  dys-
unction,  and  hemodynamic  instability  necessitate  surgical
reatment  [2].
Neurobrucellosis  can  be  seen  in  5%  of  cases  [3].
eningoencephalitis  is  the  most  commonly  seen  but
olyradiculoneuropathy  or  diffuse  involvement  can  also  be
een.  Direct  involvement  of  the  central  nervous  system  with
he  agent  and  autoimmune  mechanisms  can  be  responsible
or  neurobrucelosis  [3].  Diagnosis  can  be  made  by  isolation  of
he  agent  in  CSF  and  high  antibody  titers.  Besides  those,  lym-
hocytosis,  decreased  glucose  levels,  and  elevated  protein
oncentration  in  CSF  support  the  diagnosis  [11]. Cerebrovas-
ular  involvement  and  mycotic  aneurysm  formation  are  rare
n  neurobrucellosis.  Embolization  of  endocarditis  or  arteri-
is  as  a  result  of  vascular  inﬂammation  can  be  responsible
or  cerebrovascular  involvement.  Lacunar  infarcts,  hemor-
hages,  and  venous  thrombosis  may  result  in  various  clinical
resentations  [12]. In  our  case  intraparencyhmal  hematoma
nd  right  posterior  cerebral  artery  aneurysm  formation  were
een.  Vascular  involvement  in  neurobrucellosis  may  lead  to
linical  presentations  that  necessitate  urgent  intervention
nd  the  mortality  rate  of  neurobrucellosis  is  about  0.5—5%
3].
Long-term  treatment  is  necessary  for  brucella  infections,
ecause  it  is  an  intracellular  infection.  Five  months  before
is  admission,  our  case  was  admitted  to  another  hospital
ith  symptoms  of  fever,  night  sweats,  and  weight  loss,  and
e  was  diagnosed  as  having  a  brucella  infection.  Antibiotic
herapy  was  given  to  the  patient,  but  the  patient  stopped  his
reatment  himself  before  the  completion  of  the  ideal  treat-
ent  duration.  And  as  a  result  of  this,  infection  control  could
ot  be  established.  Progression  of  the  untreated  infection  to
he  bicuspid  aortic  valve  resulted  in  infective  endocarditis.
eptic  embolisms  as  a  result  of  infective  endocarditis  can
ave  a  role  in  the  development  of  neurobrucellosis  which
ccounts  for  the  central  nervous  system  manifestations.
esides  these,  mycotic  aneuyrsm  and  intracranial  bleeding
esulting  from  vasculitic  involvement  of  cerebral  arteries,
nd  CSF  transmission  of  reactive  proteins  and  inﬂammatory
ediators  also  may  have  a  role  in  the  development  of  neu-
obrucellosis.
Doxycycline,  rifampicin,  streptomycin,  co-trimoxazole,eftriaxone,  or  ciproﬂoxacin  can  be  used  in  the  treat-
ent  of  neurobrucellosis  and  brucella  endocarditis.  Because
f  intracellular  involvement  and  antibiotic  resistance,
ifampicin,  doxycycline  and  co-trimoxazole  treatment  is
[R.E.  Altekin  et  al.
ecommended  for  6—12  months  [2,3]. Bicuspid  aortic  valve
nd  mechanical  complications  required  surgical  treatment
ith  medical  therapy  in  our  case.  Because  of  high  complica-
ion  risk  and  low  success  rate  of  endovascular  treatment
ithout  infection  control  and  the  patient’s  neurological
tability,  intervention  for  the  aneurysm  was  planned  after
nfection  control  and  aortic  valve  surgery.  Endovascular
reatment  of  mycotic  aneuryms  caused  by  neurobrucellosis
an  be  achieved  safely  after  the  infection  and  vascular
nﬂammation  is  taken  under  control.  In  case  of  fever  of
nknown  origin  and  neurologic  ﬁndings  the  diagnosis  of  neu-
obrucellosis  should  be  kept  in  mind  and  it  should  not  be
orgotten  that  endocarditis  could  accompany  neurobrucel-
osis.
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